Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

OBJECTIVE: Recent reports have implicated the p53 tumor suppressor in the regulation of lipid metabolism. We hypothesized that the pharmacological activation of p53 with low-dose doxorubicin, which is widely used to treat several types of cancer, may have beneficial effects on nonalcoholic fatty liv...

詳細記述

保存先:
書誌詳細
出版年:Mol Metab
主要な著者: Porteiro, Begoña, Fondevila, Marcos F., Buque, Xabier, Gonzalez-Rellan, Maria J., Fernandez, Uxia, Mora, Alfonso, Beiroa, Daniel, Senra, Ana, Gallego, Rosalia, Fernø, Johan, López, Miguel, Sabio, Guadalupe, Dieguez, Carlos, Aspichueta, Patricia, Nogueiras, Rubén
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2017
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5985045/
https://ncbi.nlm.nih.gov/pubmed/29290620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2017.12.005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料